BASI Financial Facts

Income tax benefit: 1K
Product revenue: 1.2M
See Full Income Statement

Cash and cash equivalents: 536K
Total shareholders' equity: 9.98M
See Full Balance Sheet

Bioanalytical Systems (BASI) Earnings

  |   Expand Research on BASI
Next EPS Date 8/14/15 *Est. EPS Growth Rate +66.7% *Last Qtr.
Average EPS % Beat Rate -125.0% Revenue Growth Rate -3.0% *Last Qtr.
Average % Move 1-Wk after EPS +8.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/14/15 Q215 -$0.01N/A N/A $5.73M$5.92M N/A Details
2/12/15 Q115 $0.01N/A N/A $5.85M$6.22M N/A Details
12/22/14 Q414 -$0.02N/A N/A $6.42M$5.51M N/A Details
8/14/14 Q314 $0.02N/A N/A $6.03M$5.6M N/A Details
5/15/14 Q214 -$0.03N/A N/A $5.91M$5.16M N/A Details
2/13/14 Q114 $0.04N/A N/A $6.22M$5.8M N/A Details
12/24/13 Q413 $0.03N/A N/A $5.51M$6.54M N/A Details
10/18/13 Q313 $0.07$0.01 +$0.06$5.6M$5.65M N/A Details